Evidence for Magnesium as Sleep Aid Has Remained Inconsistent
A new review suggests the supplement may not improve sleep despite its surging popularity.
Updated on Oct. 14, 2026 in Sleep Disorders
Live Poll
Do you trust personal testimonials as much as clinical trials when choosing health supplements?
A systematic review of 12 placebo-controlled trials has concluded that evidence supporting magnesium as an effective sleep aid is inconsistent and of low certainty. The findings arrive as consumer interest in the mineral continues to climb, with millions searching for it online as a potential remedy for rest issues.
Why it matters
While magnesium has become a leading supplement for sleep and mood, this review suggests current research does not reliably support its routine use for insomnia. These findings help clarify the gap between anecdotal claims and rigorous clinical evidence for individuals seeking to manage their sleep health.
A systematic review analyzed 12 placebo-controlled randomized clinical trials to evaluate magnesium's efficacy for sleep. The researchers found that the overall evidence is of low certainty, and many studies exhibited a medium-to-high risk of bias.
The players
Holland & Barrett
A major health and wellness retailer that identified magnesium as the most searched ingredient in 2025.
The details
The review compared existing clinical studies by analyzing factors such as participant population, dosage, duration, and overall study quality. Because many of the trials relied on self-reported sleep quality rather than objective monitoring, the results were difficult to synthesize into a clear recommendation. Additionally, some participants involved in the research reported non-serious gastrointestinal disturbances.
Timeline
2022 served as the baseline year for comparing magnesium supplement sales growth.
North American magnesium sales reached $336 million in the 12 months leading to June 2024.
The global magnesium supplements market was valued at $4.7 billion in 2025.
Market value is projected to reach nearly $9 billion by 2034.
Health Landscape
The global magnesium market is currently valued at $4.7 billion and is projected to reach $9 billion by 2034. This review highlights a widening disconnect between widespread consumer use of sleep-focused supplements and the clinical data required to support their efficacy.
If you are experiencing persistent sleep difficulties, these findings suggest that turning to magnesium supplements as a primary solution may not be effective. It is worth discussing your sleep quality and potential non-pharmacological interventions with your doctor rather than relying on popular supplements.
The takeaway
The takeaway is that common sleep supplements often lack the rigorous clinical validation necessary to justify their widespread use. Always consult your primary care physician to develop a safe and evidence-backed plan for addressing persistent sleep or energy concerns.
Further reading
For more information on managing your sleep habits, visit our Sleep Disorders section.
More information
Read the full systematic review of magnesium trials for more detail on the analyzed study methodologies.
Source note: This article includes information reported by NutraIngredients.
Live Poll
Do you trust personal testimonials as much as clinical trials when choosing health supplements?
